IDSA Guidelines on Serologic Testing for the Diagnosis of COVID-19
Infectious Diseases Society of America has released Guidelines on Serologic Testing for the Diagnosis of COVID-19. IDSA's goal was to develop evidence-based recommendations that assist clinicians, clinical laboratories, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 serologic tests in a variety of settings. The guidelines also highlight important unmet research needs pertaining to the use of anti-SARS-CoV-2 antibody tests for diagnosis, public health surveillance, vaccine development and the selection of convalescent plasma donors.
Main recommendations include-